A transformative $200 million gift to NYU Long Island School of Medicine will ensure generations of medical students continue to receive a tuition-free, top-quality education focused on primary care.
Verve raises $148M via public stock offering, private placement with Eli Lilly (corrected)
After releasing the first-ever results of an in vivo base editing therapy in humans, Verve Therapeutics has priced a public offering of 12.5 million shares